Detalhe da pesquisa
1.
Neuropilin-1 and placental growth factor as prognostic factors in metastatic breast cancer.
BMC Cancer
; 24(1): 331, 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38468231
2.
High baseline Tie1 level predicts poor survival in metastatic breast cancer.
BMC Cancer
; 19(1): 732, 2019 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31340773
3.
Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial.
J Clin Oncol
; 40(10): 1051-1058, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35020465
4.
Phase 1 Lymfactin® Study: 24-month Efficacy and Safety Results of Combined Adenoviral VEGF-C and Lymph Node Transfer Treatment for Upper Extremity Lymphedema.
J Plast Reconstr Aesthet Surg
; 75(11): 3938-3945, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151039
5.
Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM).
Eur J Cancer
; 127: 173-182, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648851
6.
Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer.
Clin Breast Cancer
; 19(4): e522-e533, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31029558
7.
Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer: The Randomized Clinical FinXX Trial.
JAMA Oncol
; 3(6): 793-800, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28253390
8.
Bevacizumab Combined with Docetaxel or Paclitaxel as First-line Treatment of HER2-negative Metastatic Breast Cancer.
Anticancer Res
; 36(12): 6431-6438, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27919965